SCHEMBL15074765

SCHEMBL15074765

O=C1OCC(C(=O)NCCCCCCNC(=O)C2COC(=O)O2)O1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.51
POLB P06746 1/20 0.48
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
GAA P10253 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
TSHR P16473 1/20 0.43
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16493476 0.92 HPGD (0.59) HPGDPOLBNAAA
SCHEMBL15074767 0.92 HPGD (0.59) HPGDPOLBNAAA
SCHEMBL16335507 0.92 HPGD (0.59) HPGDPOLBNAAA
SCHEMBL19688991 0.91 HPGD (0.45) HPGDPOLBMEN1KMT2AGAA
SCHEMBL19688989 0.89 HPGD (0.47) HPGDPOLBMEN1KMT2AGAA
SCHEMBL15057598 0.88 HPGD (0.66) HPGDPOLBMEN1KMT2AGAA
SCHEMBL19320497 0.80 POLB (0.42) HPGDPOLBMEN1KMT2AGAA
SCHEMBL15933869 0.79 GAA (0.39) HPGDPOLBMEN1KMT2AGAA
SCHEMBL17327999 0.78 GAA (0.36) HPGDPOLBMEN1KMT2AGAA
SCHEMBL17327998 0.78 GAA (0.36) HPGDPOLBMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200339846-A1 USE OF COMPOUNDS HAVING N 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDE UNITS IN TWO-COMPONENT ADHESIVES BASF SE (DE) 2020-10-29 US disclosed
US-20200165373-A1 CURABLE ORGANIC POLYMER COMPRISING AT LEAST ONE ACYLUREA UNIT, ITS PREPARATION AND USE SIKA TECHNOLOGY AG (CH) 2020-05-28 US disclosed
US-10590227-B2 Curable organic polymer comprising at least one acylurea unit, its preparation and use CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2020-03-17 US disclosed
US-20170253687-A1 A CURABLE ORGANIC POLYMER COMPRISING AT LEAST ONE ACYLUREA UNIT, ITS PREPARATION AND USE SIKA TECHNOLOGY AG (CH) 2017-09-07 US disclosed
US-20170008871-A1 2-HYDROXYETHYL 2-OXO-1,3-DIOXOLANE-4-CARBOXYLATES, THEIR PREPARATION AND USE SIKA TECHNOLOGY AG (CH) 2017-01-12 US disclosed
EP-2794585-B1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE CONSTR RES & TECH GMBH (DE) 2016-06-15 EP disclosed
US-9309218-B2 2-Oxo-1,3-dioxolane-4-carboxamides, their preparation and use CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2016-04-12 US disclosed
WO-2016041666-A1 A CURABLE ORGANIC POLYMER COMPRISING AT LEAST ONE ACYLUREA UNIT, ITS PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2016-03-24 WO disclosed
EP-2998331-A1 A curable organic polymer comprising at least one acylurea unit, its preparation and use Construction Research & Technology GmbH (DE) 2016-03-23 EP disclosed
WO-2015132080-A1 2-HYDROXYETHYL 2-OXO-1, 3-DIOXOLANE-4-CARBOXYLATES, THEIR PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2015-09-11 WO disclosed
EP-2915808-A1 2-Hydroxyethyl 2-oxo-1,3-dioxolane-4-carboxylates, their preparation and use Construction Research & Technology GmbH (DE) 2015-09-09 EP disclosed
US-20150051365-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE SIKA TECHNOLOGY AG (CH) 2015-02-19 US disclosed
WO-2013092011-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170008871-A1 2-HYDROXYETHYL 2-OXO-1,3-DIOXOLANE-4-CARBOXYLATES, THEIR PREPARATION AND USE HAO2, OXGR1, HAO1 HPGD 138/4885POLB 1071/4885MEN1 3450/4885
US-20150051365-A1 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE HAO2, OXGR1, AOX1 HPGD 170/4885POLB 610/4885MEN1 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.